Genlong Xue[Author] - Search Results

Year	Number of Results
2016	1
2017	1
2018	2
2019	2
2020	1
2021	4
2022	8
2023	2
2024	0

1

Interdependent Nuclear Co-Trafficking of ASPP1 and p53 Aggravates Cardiac Ischemia/Reperfusion Injury.

Yang Y, Zhang Y, Yang J, Zhang M, Tian T, Jiang Y, Liu X, Xue G, Li X, Zhang X, Li S, Huang X, Li Z, Guo Y, Zhao L, Bao H, Zhou Z, Song J, Yang G, Xuan L, Shan H, Zhang Z, Lu Y, Yang B, Pan Z. Yang Y, et al. Among authors: xue g. Circ Res. 2023 Jan 20;132(2):208-222. doi: 10.1161/CIRCRESAHA.122.321153. Epub 2022 Dec 30. Circ Res. 2023. PMID: 36656967 Free PMC article.

2

Benefits of SGLT2 inhibitors in arrhythmias.

Gao J, Xue G, Zhan G, Wang X, Li J, Yang X, Xia Y. Gao J, et al. Among authors: xue g. Front Cardiovasc Med. 2022 Oct 20;9:1011429. doi: 10.3389/fcvm.2022.1011429. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337862 Free PMC article. Review.

3

The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia-reperfusion injury.

Zhang Y, Zhang X, Cai B, Li Y, Jiang Y, Fu X, Zhao Y, Gao H, Yang Y, Yang J, Li S, Wu H, Jin X, Xue G, Yang J, Ma W, Han Q, Tian T, Li Y, Yang B, Lu Y, Pan Z. Zhang Y, et al. Among authors: xue g. Nat Commun. 2021 Jan 22;12(1):522. doi: 10.1038/s41467-020-20844-3. Nat Commun. 2021. PMID: 33483496 Free PMC article.

4

Transcription factor Meis1 act as a new regulator of ischemic arrhythmias in mice.

Liu Y, Li J, Xu N, Yu H, Gong L, Li Q, Yang Z, Li S, Yang J, Huang D, Xue Y, Xue G, Liu J, Chen H, Zhang R, Li A, Zhao Y, Li P, Li M, Liu M, Wang N, Cai B. Liu Y, et al. Among authors: xue g. J Adv Res. 2022 Jul;39:275-289. doi: 10.1016/j.jare.2021.11.004. Epub 2021 Nov 15. J Adv Res. 2022. PMID: 35777912 Free PMC article.

5

Cytoplasmic sequestration of p53 by lncRNA-CIRPILalleviates myocardial ischemia/reperfusion injury.

Jiang Y, Yang Y, Zhang Y, Yang J, Zhang MM, Li S, Xue G, Li X, Zhang X, Yang J, Huang X, Huang Q, Shan H, Lu Y, Yang B, Pan Z. Jiang Y, et al. Among authors: xue g. Commun Biol. 2022 Jul 18;5(1):716. doi: 10.1038/s42003-022-03651-y. Commun Biol. 2022. PMID: 35851102 Free PMC article.

6

Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution.

Zhang R, Liu J, Xue G, Yang J, Li D, Tian T, Zhang X, Gao K, Pan Z. Zhang R, et al. Among authors: xue g. Gene Ther. 2023 Feb;30(1-2):142-149. doi: 10.1038/s41434-022-00348-z. Epub 2022 May 30. Gene Ther. 2023. PMID: 35644811

7

Knockout of interleukin-17A diminishes ventricular arrhythmia susceptibility in diabetic mice via inhibiting NF-κB-mediated electrical remodeling.

Li DS, Xue GL, Yang JM, Li CZ, Zhang RX, Tian T, Li Z, Shen KW, Guo Y, Liu XN, Wang J, Lu YJ, Pan ZW. Li DS, et al. Acta Pharmacol Sin. 2022 Feb;43(2):307-315. doi: 10.1038/s41401-021-00659-8. Epub 2021 Apr 28. Acta Pharmacol Sin. 2022. PMID: 33911193 Free PMC article.

8

Cullin-associated and neddylation-dissociated 1 protein (CAND1) governs cardiac hypertrophy and heart failure partially through regulating calcineurin degradation.

Li X, Zhang Y, Zhao Y, Zhou Y, Han Q, Yang Y, Zhang L, Shi L, Jin X, Zhang R, Gao H, Xue G, Li D, Zhang ZR, Lu Y, Yang B, Pan Z. Li X, et al. Among authors: xue g. Pharmacol Res. 2022 Aug;182:106284. doi: 10.1016/j.phrs.2022.106284. Epub 2022 May 31. Pharmacol Res. 2022. PMID: 35661710

9

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis.

Li J, Xu C, Liu Y, Li Y, Du S, Zhang R, Sun Y, Zhang R, Wang Y, Xue H, Ni S, Asiya M, Xue G, Li Y, Shi L, Li D, Pan Z, Zhang Y, Wang Z, Cai B, Wang N, Yang B. Li J, et al. Among authors: xue g. Basic Res Cardiol. 2020 Jan 4;115(2):9. doi: 10.1007/s00395-019-0768-4. Basic Res Cardiol. 2020. PMID: 31900593

10

Sodium-Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice.

Xue G, Yang X, Zhan G, Wang X, Gao J, Zhao Y, Wang X, Li J, Pan Z, Xia Y. Xue G, et al. Front Pharmacol. 2022 Oct 14;13:988408. doi: 10.3389/fphar.2022.988408. eCollection 2022. Front Pharmacol. 2022. PMID: 36313361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year